H. R. 1117 aims to amend the Federal Food, Drug, and Cosmetic Act by restricting the advertising of drugs directly to consumers. The bill prohibits such advertising for the first three years after a drug is approved. However, there is an option for a waiver during the third...
Simple Explanation
H. R. 1117 is a rule that says new medicines can't show TV ads or ads to people for three years after they start being used, but they might allow it a little earlier if it's really good for people’s health. If a medicine has bad side effects after it's sold, they can stop its ads anytime.